Claudio Albrecht | Former CEO and Chairman of the Board of Directors, Actavis Group, Founder and Managing Partner
Albrecht, Prock & Partners AG

Claudio Albrecht has more than 26 years' experience in the global pharmaceutical and generics industries. Until recently, he was CEO and Chairman of the Board of the Actavis Group, a global integrated speciality pharmaceutical company, which became the third largest generics company worldwide following the acquisition by US company Watson.

Claudio was formerly CEO of the Ratiopharm Group, one of Europe's leading generics companies headquartered in Germany. He started his pharmaceutical career at Sandoz, the generic pharmaceuticals division of Novartis, where he had responsibility for running the Sandoz generics businesses in the Netherlands, Germany and the US respectively.